Page 781 - Williams Hematology ( PDFDrive )
P. 781

756            Part VI:  The Erythrocyte                                                                                                                    Chapter 48:  The Thalassemias: Disorders of Globin Synthesis           757




                 94.  Kazazian HH, Orkin SH, Boehm CD, et al: Characterization of a spontaneous mutation     128. Menzel S, Thein SL: Genetic architecture of hemoglobin F control. Curr Opin Hematol
                  to a beta-thalassemia allele. Am J Hum Genet 38:860, 1986.  16:179, 2009.
                 95.  Sachs AB: Messenger RNA degradation in eukaryotes. Cell 74:413, 1993.    129. Wood WG, Weatherall DJ, Clegg JB: Interaction of heterocellular hereditary persistence of
                 96.  Thermann R, Neu-Yilik J, Deters A, et al: Binary specification of nonsense codons by   foetal haemoglobin with beta thalassaemia and sickle cell anaemia. Nature 264:248, 1976.
                  splicing and cytoplasmic translation. EMBO J 17:3484, 1998.    130. Gibbons  RJ,  Wada  T:  ATRX  and  X-linked  (alpha)-thalassemia  mental  retardation
                 97.  Thein SL: Is it dominantly inherited beta thalassaemia or just a beta-chain variant that   syndrome, in Inborn Errors of Development, edited by Epstein CJ, Erickson RP, Wyn-
                  is highly unstable? Br J Haematol 107:12, 1999.        shaw-Boris A, p 748. Oxford University Press, Oxford, 2004.
                 98.  Adams JG, Steinberg MH, Boxer LA, et al: The structure of hemoglobin Indianapolis     131. Gibbons RJ, Wada T, Fisher CA, et al: Mutations in the chromatin-associated protein
                  [(beta112(G14) arginine]: An unstable variant detectable only by isotopic labeling. J   ATRX. Hum Mutat 29:796, 2008.
                  Biol Chem 254:3489, 1979.                             132. Nicholls RD, Fischel-Ghodsian N, Higgs DR: Recombination at the human alpha-
                 99.  Coleman MB, Steinberg MH, Adams JG 3rd: Hemoglobin Terre Haute arginine beta   globin gene cluster: Sequence features and topological constraints. Cell 49:369, 1987.
                  106. A posthumous correction to the original structure of hemoglobin Indianapolis.     133. Barbour VM, Tufarelli C, Sharpe JA, et al: Alpha-thalassemia resulting from a negative
                  Blood 76:57, 1990.                                     chromosomal position effect. Blood 96:800, 2000.
                 100. Thein SL, Wood WG, Wickramasinghe SN, Galvin MC: Beta-thalassemia unlinked to     134. Tufarelli C, Stanley JA, Garrick D, et al: Transcription of antisense RNA leading to gene
                  the beta-globin gene in an English family. Blood 82:961, 1993.  silencing and methylation as a novel cause of human genetic disease. Nat Genet 34:157, 2003.
                 101. Jones RW, Old JM, Trent RJ, et al: Major rearrangement in the human beta-globin gene     135. Wilkie AOM, Lamb J, Harris PC, et al: A truncated human chromosome 16 associ-
                  cluster. Nature 291:39, 1981.                          ated with alpha thalassaemia is stabilized by addition of telomeric repeat (TTAGGG).
                 102. Baglioni C: The fusion of two peptide chains in hemoglobin Lepore and its interpreta-  Nature 346:868, 1990.
                  tion as a genetic deletion. Proc Natl Acad Sci U S A 48:1880, 1962.    136. Hatton CS, Wilkie AO, Drysdale HC, et al: Alpha-thalassemia caused by a large (62 kb)
                 103. Ottolenghi S, Giglioni B, Pulazzini A, et al: Sardinian delta beta zero-thalassemia: a   deletion upstream of the human alpha globin gene cluster. Blood 76:221, 1990.
                  further example of a C to T substitution at position –196 of the A gamma globin gene     137. Liebhaber SA, Griese E-U, Cash FE, et al: Inactivation of human alpha-globin gene
                  promoter. Blood 69:1058, 1987.                         expression by a de novo deletion located upstream of the alpha-globin gene cluster. Proc
                 104. Atweh GF, Zhu XX, Brickner HE, et al: The beta-globin gene on the Chinese delta   Natl Acad Sci U S A 81:9431, 1990.
                  beta-thalassemia chromosome carries a promoter mutation. Blood 70:1480, 1987.    138. Embury SH, Miller JA, Dozy AM, et al: Two different molecular organizations account
                 105. Wainscoat JS, Thein SL, Wood WG, et al: A novel deletion in the beta globin gene com-  for the single alpha-globin gene of the alpha-thalassemia-2 genotype.  J Clin Invest
                  plex. Ann N Y Acad Sci 445:20, 1985.                   66:1319, 1980.
                 106. Kulozik A, Yarwood N, Jones RW: The Corfu delta beta zero thalassemia: A small deletion     139. Higgs DR, Old JM, Pressley L, et al: A novel alpha-globin gene arrangement in man.
                  acts at a distance to selectively abolish beta globin gene expression. Blood 71:457, 1988.  Nature 284:632, 1980.
                 107. Fritsch EF, Lawn RM, Maniatis T: Characterization of deletions which affect the expres-    140. Goossens M, Dozy AM, Embury SH, et al: Triplicated alpha-globin loci in humans.
                  sion of fetal globin genes in man. Nature 279:598, 1979.  Proc Natl Acad Sci U S A 77:518, 1980.
                 108. Orkin SH, Goff SC, Nathan DG: Heterogeneity of DNA deletion in gamma delta     141. Trent RJ, Higgs DR, Clegg JB, Weatherall DJ: A new triplicated alpha-globin gene
                  beta-thalassemia. J Clin Invest 67:878, 1981.          arrangement in man. Br J Haematol 49:149, 1981.
                 109. Pirastu M, Kan YW, Lin CC, et al: Hemolytic disease of the newborn caused by a new     142. Higgs DR, Hill AVS, Bowden DK, Weatherall DJ: Independent recombination events
                  deletion of the entire beta-globin cluster. J Clin Invest 72:602, 1983.  between duplicated human alpha globin genes: Implications for their concerted evolu-
                 110. Fearon ER, Kazazian HH Jr, Waber PG, et al: The entire beta-globin gene cluster is   tion. Nucleic Acids Res 12:6965, 1984.
                  deleted in a form of gamma delta beta-thalassemia. Blood 61:1269, 1983.    143. Orkin SH, Goff SC, Hechtman RL: Mutation in an intervening sequence splice junction
                 111. Van der Ploeg LH, Konings A, Oort M, et al: gamma-beta-Thalassaemia studies show-  in man. Proc Natl Acad Sci U S A 78:5041, 1981.
                  ing that deletion of the gamma- and delta-genes influences beta-globin gene expression     144. Higgs DR, Goodbourn SE, Lamb J, et al: Alpha-thalassaemia caused by a polyadenyla-
                  in man. Nature 283:637, 1980.                          tion signal mutation. Nature 306:398, 1983.
                 112. Curtin P, Pirastu M, Kan YW, et al: A distant gene deletion affects beta-globin gene     145. Thein SL, Wallace RB, Pressley L, et al: The polyadenylation site mutation in the alpha-
                  function in an gamma delta beta-thalassemia. J Clin Invest 76:1554, 1985.  globin gene cluster. Blood 71:313, 1988.
                 113. Driscoll MC, Dobkin CS, Alter BP: Gamma delta beta-thalassemia due to a de novo     146. Pirastu M, Saglio G, Chang JC, et al: Initiation codon mutation as a cause of alpha
                  mutation deleting the 5′ beta-globin gene activation-region hypersensitive sites. Proc   thalassemia. J Biol Chem 259:12315, 1984.
                  Natl Acad Sci U S A 86:7480, 1989.                    148. Olivieri NF, Chang LS, Poon AO, et al: An alpha-globin gene initiation codon mutation
                 114. Tuan D, Feingold E, Newman M, et al: Different 3′ end points of deletions causing delta   in a black family with HbH disease. Blood 70:729, 1987.
                  beta-thalassemia and hereditary persistence of fetal hemoglobin: Implications for the     148. Paglietti E, Galanello R, Moi P, et al: Molecular pathology of haemoglobin H disease in
                  control of gamma-globin gene expression in man. Proc Natl Acad Sci U S A 80:6937, 1983.  Sardinians. Br J Haematol 63:485, 1986.
                 115. Kendall AG, Ojwang PJ, Schroeder WA, Huisman TH: Hemoglobin Kenya, the product     149. Morlé F, Lopez B, Henni T, Godet J: alpha-Thalassaemia associated with the deletion of
                  of a gamma-beta fusion gene: Studies of the family. Am J Hum Genet 25:548, 1973.  two nucleotides at position –2 and –3 preceding the AUG codon. EMBO J 4:1245, 1985.
                 116. Smith DH, Clegg JB, Weatherall DJ, Gilles HM: Hereditary persistence of foetal haemo-    150. Weatherall DJ, Clegg JB: The alpha-chain-termination mutants and their relationship to
                  globin associated with a gamma beta fusion variant, haemoglobin Kenya. Nat New Biol   the alpha-thalassaemias. Philos Trans R Soc London B Biol Sci 271:411, 1975.
                  246:184, 1973.                                        151. Liebhaber SA, Coleman MB, Adams JG 3rd, et al: Molecular basis for nondeletion
                 117. Collins FS, Stoeckert CJ, Serjeant GR, et al: G gamma beta+ hereditary persistence of   alpha-thalassemia in American blacks. Alpha 2(116GAG—UAG). J Clin Invest 80:154, 1987.
                  fetal hemoglobin: Cosmid cloning and identification of a specific mutation 5’ to the G     152. Liebhaber SA, Kan YW: A Thalassemia caused by an unstable alpha-globin mutant. J
                  gamma gene. Proc Natl Acad Sci U S A 81:4894, 1984.    Clin Invest 71:461, 1983.
                 118. Giglioni B, Casini C, Mantovani R, et al: A molecular study of a family with Greek     153. Sanguansermsri T, Matragoon S, Changloah L, Flatz G: Hemoglobin Suan-Dok (alpha 2
                  hereditary persistence of fetal hemoglobin and beta-thalassemia. EMBO J 3:2641, 1984.  109 (G16) Leu replaced by Arg beta 2): An unstable variant associated with alpha-tha-
                 119. Gelinas R, Endlich B, Pfeiffer C, et al: G to A substitution in the distal CCAAT box of   lassemia. Hemoglobin 3:161, 1979.
                  the A gamma-globin gene in Greek hereditary persistence of fetal haemoglobin. Nature     154. Honig GR, Shamsuddin M, Zaizov R, et al: Hemoglobin Petah Tikva (alpha 110 ala
                  313:323, 1985.                                         replaced by asp): A new unstable variant with alpha-thalassemia-like expression. Blood
                 120. Tate VE, Wood WG, Weatherall DJ: The British form of hereditary persistence of fetal   57:705, 1981.
                  hemoglobin results from a single base mutation adjacent to an S1 hypersensitive site 5’     155. Honig GR, Shamsuddin M, Vida LN, et al: Hemoglobin Evanston (alpha 14 Trp—Arg).
                  to the A gamma globin gene. Blood 68:1389, 1986.       An unstable alpha-chain variant expressed as alpha-thalassemia. J Clin Invest 73:1740,
                 121. Gilman JG, Huisman TH: DNA sequence variation associated with elevated fetal G   1984.
                  gamma globin production. Blood 66:783, 1985.          156. Weatherall DJ, Higgs DR, Bunch C, et al: Hemoglobin H disease and mental retarda-
                 122. Marti HR: Normale und Abnormale Menschliche Haemoglobin. Springer-Verlag, Berlin,   tion: A new syndrome or a remarkable coincidence? N Engl J Med 305:607, 1981.
                  1963.                                                 157. Wilkie AO, Buckle VJ, Harris PC, et al: Clinical features and molecular analysis of the
                 123. Dover GJ, Smith KD, Chang YC, et al: Fetal hemoglobin levels in sickle cell disease and   alpha thalassemia/mental retardation syndromes: I. Cases due to deletions involving
                  normal individuals are partially controlled by an X-linked gene located at Xp22.2. Blood   chromosome band 16p13.3. Am J Hum Genet 46:1112, 1990.
                  80:816, 1992.                                         158. Wilkie AO, Zeitlin HC, Lindenbaum RH, et al: Clinical features and molecular analysis
                 124. Craig JE, Rochette J, Fisher CA, et al: Dissecting the loci controlling fetal haemoglobin   of the alpha-thalassemia/mental retardation syndromes: II. Cases without detectable
                  production on chromosomes 11p and 6q by the regressive approach. Nat Genet 12:58,   abnormality of the alpha globin complex. Am J Hum Genet 46:1127, 1990.
                  1996.                                                 159. Gibbons RJ, Suthers GK, Wilkie AO, et al: X-linked alpha-thalassemia/mental retar-
                 125. Garner C, Silver N, Best S, et al: Quantitative trait loci on chromosome 8q influences   dation (ATR-X) syndrome: Localization to Xq12–21.31 by X-inactivation and linkage
                  the switch from fetal to adult hemoglobin. Blood 104:2184, 2004.  analysis. Am J Hum Genet 51:1136, 1992.
                 126. Menzel S, Garner C, Gut I, et al: A QTL influencing F cell production maps to a gene     160. Gibbons RJ, Picketts DJ, Villard L, Higgs DR: Mutations in a putative global transcrip-
                  encoding a zinc-finger protein on chromosome 2p15. Nat Genet 39:1197, 2007.  tional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syn-
                 127. Uda M, Galanello R, Sanna S, et al: Genome-wide association study shows BCL11A   drome). Cell 80:837, 1995.
                  associated with persistent fetal hemoglobin and amelioration of  the phenotype of     161. Gibbons RJ, Bachoo S, Picketts DJ, et al: Mutations in transcriptional regulator ATRX
                  beta-thalassemia. Proc Natl Acad Sci U S A 105:1620, 2008.  establish the functional significance of a PHD-like domain. Nat Genet 17:146, 1997.







          Kaushansky_chapter 48_p0725-0758.indd   756                                                                   9/18/15   2:58 PM
   776   777   778   779   780   781   782   783   784   785   786